TippingPoint Biosciences: SeedDevelops novel drug discovery platform to target epigenetic targets in pediatric brain cancerOct 4, 2026RoundOSTippingPoint BiosciencesCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeed · AIBiotechUnited StatesHealthtechNorth AmericaSeed